Related Experiment Video
Updated: Jun 8, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
[A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib]
Mitsuru Komeya1, Tatsuya Matsumoto, Kiyoshi Fujinami
1The Department of Urology, Chigasaki City Hospital.
Abstract:
A 67-year-old man received left radical nephrectomy for left renal cell carcinoma (RCC) (clear cell carcinoma, G2, pT3bN0M0). After 9 months, he presented with an acute onset of left extremity edema. A computed tomographic (CT) scan and magnetic resonance imaging reveal recurrent renal cell carcinoma in the inferior vena cava (IVC) and the left renal fossa, thrombus in the left external vein and acute pulmonary embolism. We performed treatment with sunitinib for 5 months after anticoagulant therapy for 3 weeks. A new CT scan showed disappearance of RCC in the IVC and reduction in the size of RCC in the renal fossa. Only 11 cases are reported as recurrent RCC in the IVC. We report the first case of recurrent intracaval RCC in which sunitinib treatment was effective.
More Related Videos
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Treatment Resistent Cancers
Urinary Tract Calculi VI: Surgical Management

